As exclusive licensee of University of California San Francisco's (UCSF) metagenomic sequencing (mNGS) technology, Delve Bio is now the exclusive provider of the UCSF mNGS test...
At Delve, we are scaling our proprietary, ground-breaking metagenomic sequencing (mNGS) technology to give labs and clinicians the tool they need to move from "what's wrong" to "what's next." Our team includes some of the most experienced and respected researchers, clinicians, investors and entrepreneurs in the world, working together to make mNGS diagnostics standard of care...
Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.
Also known as: Delve Bio, Delve Bio Inc.